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Introduction
Pheochromocytoma is a rare and usually benign catecholamine-secreting tumor with a broad variety of signs and symptoms, 
the most common being palpitations, headaches, and sweating. Rarely, pheochromocytoma can cause severe cardiac com-
plications such as myocardial infarction, pulmonary edema or cardiogenic shock.
Case report
We report a case of a 42-year-old male who presented with acute chest pain, dyspnea, and general weakness. He had a history 
of episodical high blood pressure and panic attacks, which were unsuccessfully treated with antidepressants. The patient de-
veloped a severe left ventricular function impairment with pulmonary edema and cardiogenic shock. Coronary angiography 
showed a spasm of the right coronary artery. We suspected pheochromocytoma and performed computed tomography of 
the abdomen, which showed a large tumor in the right adrenal gland. It was confirmed to be a pheochromocytoma. The pa-
tient was treated with α-blockers, and a successful laparoscopic surgical removal of the pheochromocytoma was carried out 
eighteen days later. The patient recovered well, and symptoms of pheochromocytoma disappeared.
Conclusion
Pheochromocytoma can cause severe cardiac complications in different mechanisms, such as coronary spasm and direct cat-
echolamine toxic effect on cardiomyocites. Diagnosing and treating pheochromocytoma with cardiac complications remains 
a challenge for a physician.
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Įvadas
Feochromocitoma yra retas dažniausiai nepiktybinis katecholaminus sekretuojantis navikas, kuriam būdinga didelė simp-
tomų įvairovė. Širdies plakimo jausmas, galvos skausmas bei gausus prakaitavimas – būdingiausi pacientų skundai. Retais 
atvejais feochromocitoma komplikuojasi gyvybei grėsmingomis širdies ir kraujagyslių sistemos ligomis – miokardo infarktu, 
plaučių edema bei kardiogeniniu šoku.
Klinikinis atvejis
Į priėmimo skyrių atvykęs 42 metų amžiaus vyras skundėsi intensyviu krūtinės skausmu, dusuliu ir bendru silpnumu. Pasta-
ruoju metu pacientas buvo nesėkmingai gydomas antidepresantais dėl besikartojančių panikos atakų, kurių metu padidė-
davo arterinis kraujospūdis. Priėmimo skyriuje paciento būklė sparčiai blogėjo, progresavo ūminis kairiojo skilvelio nepakan-
kamumas, išsivystė plaučių edema bei kardiogeninis šokas. Atlikus vainikinių arterijų angiografiją, pastebėtas dešiniosios 
vainikinės arterijos distalinės dalies spazmas. Įtarus feochromocitomą, buvo atlikta pilvo kompiuterinė tomografija – rastas 
didelis navikas kairiajame antinkstyje. Laboratoriniais tyrimais patvirtinta feochromocitomos diagnozė. Aštuoniolika dienų 
pacientas buvo gydytas α-blokatoriais, vėliau sėkmingai atlikta naviko šalinimo operacija. Pooperaciniu laikotarpiu komplika-
cijų nebuvo, feochromocitomos simptomai išnyko.
Išvados
Feochromocitoma gali sukelti sunkių širdies ir kraujagyslių sistemos komplikacijų dėl įvairių katecholaminų pertekliaus po-
veikio mechanizmų. Aprašytu atveju tai buvo vainikinių arterijų spazmas bei tiesioginis toksinis katecholaminų poveikis kar-
diomiocitams. Labai didelė nespecifinių simptomų įvairovė bei galimos sunkios komplikacijos lemia tai, kad feochromocito-
mos diagnostika bei gydymas tebėra nelengvas iššūkis gydytojui.
Reikšminiai žodžiai:  feochromocitoma, hipertenzija, ūmus miokardo infarktas, katecholaminų sukelta kardiomiopatija.
Introduction
Pheochromocytoma is a rare and usually benign cate-
cholamine-secreting tumor with an incidence of 1 to 
8 cases per 1 million annually [1]. The signs and symp-
toms are associated with an increased concentration of 
catecholamines – usually noradrenalin or adrenalin, 
although some tumors produce dopamine. Classical 
symptoms of pheochromocytoma are due to intermit-
tent catecholamine secretion and include palpitations, 
headaches, sweating, and severe hypertension, lasting 
from seconds to hours. However, the presentation of 
pheochromocytoma can be much more diverse, varying 
from panic attacks to potentially life-threatening cardiac 
complications such as acute coronary syndrome and 
pulmonary edema [2]. The diagnosis is usually made 
biochemically by evaluating the levels of catecholamines 
and their metabolites metanephrines in blood plasma 
or urine. The second step in establishing the diagnosis 
is localization of the tumor, which is done by means 
of computed tomography (CT) scan or magnetic reso-
nance imaging (MRI). The treatment of choice is the 
surgical removal of pheochromocytoma, which usually 
results in the disappearance of symptoms. In this paper, 
we report a case of pheochromocytoma presenting with 
severe cardiac complications.
Case report
A 42-year-old male was admitted to the Klaipeda 
Seamen’s Hospital emergency department with acute 
chest pain, dyspnea, nausea, and general weakness. He 
had a history of psychomotor agitation attacks which 
went together with an increased blood pressure (BP) to 
240/120 mm Hg and heart rate (HR) to 130 beats per 
minute (bpm). The patient had been having this type of 
attacks 2–3 times per week for one year. He had been 
diagnosed with an anxiety disorder and panic attacks. 
He had been using antidepressants. The patient had one 
episode of paroxysmal atrial fibrillation. Coronary angio-
graphy had been performed 6 months ago in another 
hospital and showed no pathology of coronary arteries.
On examination, the patient was cyanotic, his re-
spiratory rate was 30 breaths per minute, there were 
a lot of pulmonary crackles in all the lung ausculta-
tion area, blood oxygen saturation was 82–88%. He 
had tachycardia of 140 bpm, normal heart sounds 
without cardiac murmurs; BP was 166/117 mm Hg. 
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Fig. 1. ECG on admission, showing sinus tachycardia and ST segment elevation by 2 mm in leads III, aVF and ST 
segment depression by 1 mm in leads V4, V5, V6
Fig. 2. Coronary angiography views showing a spasm of the right coronary artery and the normal left coronary artery
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The abdomen was painful in the epigastrium. There 
was no neurological deficit. The ECG showed sinus 
tachycardia of 145 bpm and ST segment elevation by 
2 mm in leads III, aVF (Fig. 1). Due to progressive 
respiratory deterioration, mechanical ventilation was 
started. We suspected acute myocardial infarction 
with ST segment elevation. Coronary angiography 
revealed a distal occlusion of the right coronary artery; 
other coronary arteries were normal (Fig. 2). We tried 
intracoronary nitrate injections, thromboaspiration, 
low-pressure balloon dilatation, but the flow was not 
restored. During the procedure, the patient developed 
a cardiogenic shock with a drop of blood pressure, so 
an intra-aortic balloon pump (IABP) was used together 
with dopamine infusion in inotropic doses. The sono-
scopy of the heart showed an akinetic apex of the heart, 
akinetic inferior wall and hypokinetic middle segments 
of the left ventricle. The ejection fraction of the left 
ventricle was reduced to 20%. The sonoscopic view 
was similar as seen in stress-induced cardiomyopathy, 
except for the inferior wall which was absolutely aki-
netic, including basal segments. The patient’s cardiac 
biomarkers (cTnI) were elevated to 7.3  ng/ml; the 
NT-ProBNP concentration of 21800 ng/ml showed a 
severe heart failure. 
Having in mind the patient’s medical history, we 
had a preliminary diagnosis of catecholamine-secreting 
tumor with catecholamine-induced cardiomyopathy 
(CIC), complicated by a cardiogenic shock. Abdominal 
sonoscopy revealed a large tumor with signs of necrosis 
in the right adrenal gland. A CT scan of the abdomen 
showed a right-sided adrenal tumor 7 cm x 6.5 cm in 
size, suspected pheochromocytoma (Fig. 3). The diagno-
sis was confirmed by the 24-hour urinary metanephrine 
level test, which found severely increased catecholamine 
metabolite levels. We had the clinical diagnosis of the 
right adrenal gland pheochromocytoma, complicated by 
CIC, myocardial infarction of the inferior wall with ST 
elevation, and cardiogenic shock.
On the 3rd day of hospitalization dopamine infusion 
was stopped, on the 4th day IABP was removed and 
mechanical ventilation was discontinued. On the same 
day we started the α1-selective alpha blocker doxazosin 
4 mg once daily. Three days later we changed doxazosin 
to phenoxybenzamine 10 mg twice daily and continued 
until the surgery. The patient was also on loop diuretics, 
spironolactone, ACE inhibitors, beta blockers and aspi-
rin – standard treatment of myocardial infarction with 
heart failure. Sonoscopy of the heart was repeated on 
the 9th day of hospitalization. It showed the hypokinetic 
inferior wall, the ejection fraction of the left ventricle 
being 45%. The apex and middle segments of the left 
ventricle were fully recovered.
The surgical removal of the right adrenal gland (right 
adrenalectomy) was planned. The patient was prepared 
for surgery and operated on the 18th day of hospitaliza-
tion. Right adrenalectomy was done laparoscopically. 
The adrenal vein was ligated first, and tumor together 
with the adrenal gland was removed. The surgical proce-
dure was successful, though there were some BP fluctua-
tions. The histological analysis of the tumor confirmed 
it was pheochromocytoma.
On the 1st postoperative day we had to discontinue 
all the antihypertensive treatment due to the low blood 
pressure. Without the drugs, the systolic blood pressure 
was between 120 and 90 mm Hg and the diastolic be-
tween 80 and 70 mm Hg. The patient was discharged 
on the 8th post-operative day.
Later, genetic testing was performed for mutations 
in the VHL and RET genes. No mutations were found.Fig. 3. CT view of the tumor in the right adrenal gland
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Discussion
Pheochromocytomas originate from chromafn cells 
of the adrenal medulla and secrete excessive amounts 
of catecholamines, most commonly noradrenalin. Due 
to the broad variety of symptoms, the most challenging 
issue in diagnosing pheochromocytoma is suspecting it. 
Only less than 0.2% of patients with hypertension have 
pheochromocytoma [3]; other most common symptoms 
such as palpitations, headaches, and sweating also lack 
specificity. Less common symptoms include orthostatic 
hypotension, visual blurring, papilledema, weight loss, 
polyuria, polydipsia, constipation, increased erythrocyte 
sedimentation rate, hyperglycemia, leukocytosis, psy-
chiatric disorders and, rarely, secondary erythrocytosis 
due to erythropoietin overproduction [4, 5]. Sometimes 
pheochromocytoma can manifest with severe cardiac 
complications such as myocardial infarction or cardiac 
failure [2, 6, 7]. The pathophysiology of myocardial dys-
function associated with pheochromocytoma has been 
linked to either a direct toxic effect of catecholamines on 
cardiomyocytes or the supply–demand mismatch and 
myocardial stunning due to microvascular dysfunction 
and the spasms of epicardial coronary arteries [8]. The 
more recently published hypothesis gives convincing 
evidence that cardiac dysfunction in stress-induced 
cardiomyopathy is caused by a direct toxic effect of a 
high catecholamine concentration on cardiomyocites. 
High levels of circulating epinephrine trigger a switch 
in intracellular signal trafcking from Gs protein to Gi 
protein signaling through the β2-adrenoreceptors. This 
change in signaling is negatively inotropic, and the effect 
is greatest at the apical myocardium in which the density 
of β-adrenoceptors is highest [9].
We suspect that the occlusion of the right coronary 
artery was due to a vasospasm. However, the spasm did 
not resolve quickly and the duration was long enough 
to cause a permanent myocardial damage. Therefore, 
repeated sonoscopy of the heart showed the remaining 
hypokinesia of the inferior wall. On the other hand, 
akinesia of the apex cannot be explained by a vasospasm, 
because coronary angiography revealed a normal blood 
flow in the left anterior descending artery. The akinesia 
of the apex disappeared completely after more than one 
week. We think that there might have been involved two 
different mechanisms of myocardial damage, which are 
a coronary spasm and the direct toxic effect of catechol-
amines on cardiomyocites. The present case shows that 
excessive amounts of catecholamines can damage the 
myocardium in both ways at the same time.
Though rarely, pheochromocytoma can compromise 
the cardiac function so severely that it leads to a car-
diogenic shock with the need of mechanical support. 
There are reports in the literature, which illustrate a suc-
cessful use of IABP or even extracorporeal membrane 
oxygenation (ECMO) in such cases [10, 11]. The use 
of inotropes or vasopressors in catecholamine-induced 
cardiomyopathy with a cardiogenic shock is debatable. 
Pheochromocytoma itself produces excessive amounts 
of catecholamines, so whether additional infusion is 
beneficial for the patients remains doubtful. In the case 
of severe left ventricular dysfunction with cardiogenic 
shock, mechanical support seems to be the method of 
choice. The calcium-sensitizing agent levosimendan 
might be a second-line pharmacological support [9]. 
Our patient was stabilized with IABP, and he received 
also dopamine infusion. The infusion was stopped as 
soon as we confirmed the diagnosis of pheochromo-
cytoma.
A widely accepted medical treatment of pheochro-
mocytoma before the surgery is α-adrenergic blockade. 
Phenoxybenzamine is an irreversible, long-acting, 
non-selective α-blocking agent and usually is a drug 
of choice, although other α-blocking agents, such as 
doxazosin, may be used. After achieving an adequate 
α-adrenergic blockade, the β-adrenergic blockade 
should be initiated. The latter blockade should not be 
started first, because it can lead to a hypertensive crisis 
by blocking peripheral vasodilatory receptors with un-
opposed alpha-adrenergic receptor stimulation.
Surgical removal of pheochromocytoma is usually 
planned at least 10 days after the initiation of an ad-
equate α- and β-adrenergic blockade. The key points of 
a successful surgical resection of pheochromocytoma are 
minimizing tumor manipulation, avoidance of tumor 
spillage, complete removal of the tumor, early ligation 
of the adrenal vein, and a good coordination with the 
anesthesiology team for the control of perioperative 
hemodynamics. The laparoscopic approach to the ad-
renal gland is the procedure of choice for patients with 
solitary intra-adrenal pheochromocytomas that are not 
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suspected to be malignant. Although the laparoscopic 
procedure might be safely performed in the majority 
of cases, sometimes laparotomy might be necessary to 
stabilize the hemodynamics [12].
Up to 24% of pheochromocytomas are familial, most 
commonly associated with multiple endocrine neoplasia 
type 2 (MEN-2) or the von Hippel-Lindau (VHL) dis-
ease [13]. Our patient was tested for mutations in VHL 
and RET genes. No mutations were found, so, most 
likely, this was a case of a sporadic pheochromocytoma.
Conclusion
The case we have presented shows that pheochromocy-
toma can cause severe cardiac dysfunction by different 
mechanisms. We believe that the prolonged vasospasm 
might have caused the infarction of the inferior left 
ventricular wall, and apical akinesia might have been a 
form of catecholamine-induced cardiomyopathy due to 
the direct toxic catecholamine effect on cardiomyocites. 
Diagnosing and treating pheochromocytoma with car-
diac complications remains a challenge for a physician.
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